Trademark: 79351724
Word
XRAYVISION
Status Date
Tuesday, January 2, 2024
Registration Number
7256776
Registration Date
Tuesday, January 2, 2024
Filing Date
Friday, September 9, 2022
Published for Opposition
Tuesday, October 17, 2023
41 Publication of the results of clinical trials for pharmaceutical preparations in the form of brochures, articles and newsletters
The mark consists of the stylized wording "XRAYVISION" with the letter "X" consisting of one bold diagonal line and three thinner diagonal lines crossing in the opposite direction.
X RAY VISION
Apr 2, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jan 2, 2024
Notice Of Registration Confirmation Emailed
Jan 2, 2024
Registered-Principal Register
Oct 17, 2023
Notification Processed By Ib
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2023
Published For Opposition
Sep 27, 2023
Notification Of Possible Opposition Sent To Ib
Sep 27, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Sep 14, 2023
Approved For Pub - Principal Register
Aug 24, 2023
Teas/Email Correspondence Entered
Aug 24, 2023
Correspondence Received In Law Office
Aug 24, 2023
Teas Response To Office Action Received
May 2, 2023
Refusal Processed By Ib
Apr 13, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 13, 2023
Refusal Processed By Mpu
Feb 23, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 22, 2023
Non-Final Action Written
Feb 10, 2023
Assigned To Examiner
Oct 11, 2022
Application Filing Receipt Mailed
Oct 7, 2022
New Application Office Supplied Data Entered
Oct 6, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
